Institutional investors purchased a net $777.0 thousand shares of ABMD during the quarter ended September 2017 and now own 89.69% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 543.8 Thousand shares of Abiomed Inc
WELLS CAPITAL MANAGEMENT, INC. Bought 341.4 Thousand shares of Abiomed Inc
FRANKLIN ADVISERS, INC. Bought 270.7 Thousand shares of Abiomed Inc